"Neuropsychiatric Disease and Treatment" . "1"^^ . "11786" . "P\u011B\u010D, Ond\u0159ej" . . "000332838500001" . . "Background: Dissociation likely plays a key role in schizophrenia and borderline personality disorder (BPD), although empirical studies that compare specific manifestations of these symptoms in schizophrenia and BPD are rare. In this context, the purpose of this study was to compare the occurrence of dissociative and other psychopathological symptoms in these disorders, and to assess the possible influence of antipsychotic medication on the dissociative symptoms. Methods: We assessed 31 patients with schizophrenia and 36 patients with BPD. Dissociative symptoms were measured by the Dissociative Experiences Scale (DES), symptoms related to stress and traumatic experiences were assessed using the Trauma Symptom Checklist-40 (TSC-40), and other psychopathological symptoms were measured with the Health of the Nation Outcome Scales (HoNOS). We also assessed actual daily doses of antipsychotic medication in chlorpromazine equivalents in all participants."@en . . . "10" . "RIV/00216224:14740/14:00079327" . "Dissociation in schizophrenia and borderline personality disorder" . "1176-6328" . "Dissociation in schizophrenia and borderline personality disorder"@en . "10.2147/NDT.S57627" . . . "NZ - Nov\u00FD Z\u00E9land" . . . "Raboch, Ji\u0159\u00ED" . . . "[7E0359B9E0D2]" . "Dissociation in schizophrenia and borderline personality disorder" . . . . . "14740" . . "March" . "Background: Dissociation likely plays a key role in schizophrenia and borderline personality disorder (BPD), although empirical studies that compare specific manifestations of these symptoms in schizophrenia and BPD are rare. In this context, the purpose of this study was to compare the occurrence of dissociative and other psychopathological symptoms in these disorders, and to assess the possible influence of antipsychotic medication on the dissociative symptoms. Methods: We assessed 31 patients with schizophrenia and 36 patients with BPD. Dissociative symptoms were measured by the Dissociative Experiences Scale (DES), symptoms related to stress and traumatic experiences were assessed using the Trauma Symptom Checklist-40 (TSC-40), and other psychopathological symptoms were measured with the Health of the Nation Outcome Scales (HoNOS). We also assessed actual daily doses of antipsychotic medication in chlorpromazine equivalents in all participants." . . "Dissociation in schizophrenia and borderline personality disorder"@en . "http://www.dovepress.com/dissociation-in-schizophrenia-and-borderline-personality-disorder-peer-reviewed-article-NDT" . "dissociation; stress-related symptoms; schizophrenia; borderline personality disorder; antipsychotic medication"@en . . "5"^^ . . "I, P(ED1.1.00/02.0068), P(LH11032)" . . "RIV/00216224:14740/14:00079327!RIV15-MSM-14740___" . "3"^^ . "Bob, Petr" .